The Government of Japan has announced an emergency grant of USD 500,000 to the International Federation of Red Cross and Red Crescent Societies to support Uganda's efforts in containing the Ebola outbreak. This financial assistance aims to strengthen the country's response to the health crisis, according to Business Times.

A trial for potential treatments targeting the Ebola virus responsible for the current outbreak in the Democratic Republic of Congo has commenced, as announced by the World Health Organization (WHO). The first patient has been enrolled in the trial, which follows reports of over 1,400 cases and 438 deaths related to the outbreak, according to WHO chief Tedros Adhanom Ghebreyesus.

Uganda recently closed its border with the Democratic Republic of Congo to prevent the spread of Ebola, as the Congo faces a significant outbreak with over 1,000 suspected and confirmed cases and more than 250 deaths reported as of May 27, 2026, according to the U.S. Centers for Disease Control. Public health experts suggest that such border closures may not be the most effective strategy in managing the outbreak.

As Uganda enhances border surveillance to prevent Ebola from the Democratic Republic of Congo, allegations have surfaced that Congolese nationals are bribing security personnel for entry. The extensive border, over 1,000 kilometers long, runs from Koboko to Kisoro, highlighting the challenges faced in maintaining effective border control amid the health crisis.

Residents in eastern Congo are hopeful as a new clinical trial for Ebola treatments has commenced at the Evangelical Medical Center in Bunia. Researchers are testing two experimental treatments in response to the ongoing Ebola outbreak in the region, aiming to combat the disease's spread.

The World Health Organization (WHO) is set to launch a clinical trial in the Democratic Republic of the Congo (DRC) next week to assess the effectiveness of two antiviral treatments, MBP134 and remdesivir, in reducing mortality among patients infected with Bundibugyo virus disease. This initiative comes as reported cases of the disease exceed 1,000. The trial will evaluate the treatments both individually and in combination, with preparations now complete.